Anti-G3ST3/ GAL3ST3/ GAL3ST-3 functional antibody
Anti-G3ST3/ GAL3ST3/ GAL3ST-3 functional antibody for cell culture, ELISA & in-vivo assay
Go to GAL3ST3/GAL3ST3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0231-Ab-1/ GM-Tg-hg-SE0231-Ab-2 | Anti-Human GAL3ST3 monoclonal antibody | Human |
GM-Tg-rg-SE0231-Ab-1/ GM-Tg-rg-SE0231-Ab-2 | Anti-Rat GAL3ST3 monoclonal antibody | Rat |
GM-Tg-mg-SE0231-Ab-1/ GM-Tg-mg-SE0231-Ab-2 | Anti-Mouse GAL3ST3 monoclonal antibody | Mouse |
GM-Tg-cynog-SE0231-Ab-1/ GM-Tg-cynog-SE0231-Ab-2 | Anti-Cynomolgus/ Rhesus macaque GAL3ST3 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0231-Ab-1/ GM-Tg-felg-SE0231-Ab-2 | Anti-Feline GAL3ST3 monoclonal antibody | Feline |
GM-Tg-cang-SE0231-Ab-1/ GM-Tg-cang-SE0231-Ab-2 | Anti-Canine GAL3ST3 monoclonal antibody | Canine |
GM-Tg-bovg-SE0231-Ab-1/ GM-Tg-bovg-SE0231-Ab-2 | Anti-Bovine GAL3ST3 monoclonal antibody | Bovine |
GM-Tg-equg-SE0231-Ab-1/ GM-Tg-equg-SE0231-Ab-2 | Anti-Equine GAL3ST3 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0231-Ab-1/ GM-Tg-hg-SE0231-Ab-2; GM-Tg-rg-SE0231-Ab-1/ GM-Tg-rg-SE0231-Ab-2; GM-Tg-mg-SE0231-Ab-1/ GM-Tg-mg-SE0231-Ab-2; GM-Tg-cynog-SE0231-Ab-1/ GM-Tg-cynog-SE0231-Ab-2; GM-Tg-felg-SE0231-Ab-1/ GM-Tg-felg-SE0231-Ab-2; GM-Tg-cang-SE0231-Ab-1/ GM-Tg-cang-SE0231-Ab-2; GM-Tg-bovg-SE0231-Ab-1/ GM-Tg-bovg-SE0231-Ab-2; GM-Tg-equg-SE0231-Ab-1/ GM-Tg-equg-SE0231-Ab-2 |
Products Name | Anti-GAL3ST3 monoclonal antibody |
Format | mab |
Target Name | GAL3ST3 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-GAL3ST3 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0231-Ag-1 | Recombinant multi-species G3ST3/ GAL3ST3/ GAL3ST-3 protein |
ORF Viral Vector | pGMAAV000272 | house mouse Gal3st3 AAV plasmid |
ORF Viral Vector | vGMAAV000272 | house mouse Gal3st3 AAV particle |
Target information
Target ID | GM-SE0231 |
Target Name | GAL3ST3 |
Gene ID | 89792,545276,499302,714845,483717,101081672,523401,100052111 |
Gene Symbol and Synonyms | GAL3ST-3,GAL3ST2,GAL3ST3 |
Uniprot Accession | Q96A11,Q0VCH4 |
Uniprot Entry Name | G3ST3_HUMAN,G3ST3_BOVIN |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000175229 |
Target Classification | N/A |
The target: GAL3ST3, gene name: GAL3ST3, also named as GAL3ST-3, GAL3ST2. This gene encodes a member of the galactose-3-O-sulfotransferase protein family. The product of this gene catalyzes sulfonation by transferring a sulfate group to the 3' position of galactose in N-acetyllactosamine in both type 2 (Gal-beta-1-4GlcNAc-R) oligosaccharides and core-2-branched O-glycans, but not on type 1 or core-1-branched structures. This gene, which has also been referred to as GAL3ST2, is different from the GAL3ST2 gene located on chromosome 2 that encodes a related enzyme with distinct tissue distribution and substrate specificities, compared to galactose-3-O-sulfotransferase 3. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.